Latest Path Report, good thing its gone.

[mcgle]

Hi Chelee

Don’t want to worry you, but I think it is possible to have cancer in the nodes, though nothing infiltrating is found in the breast. The reason I say this is because I know of someone who had ‘just’ DCIS, and was found to have micromets in the nodes (she is HER2+). However, her DCIS was extensive and high grade, a totally different scenario to yours. I hope you get to the bottom of what is causing this pain.<O:p</O:p

Mcgle<O:p</O:p

[Becky]

Chelee

What your surgeon is telling you is true except for the fact that not all hyperplasia turns to DCIS and then cancer. It is well documented that not all DCIS turns to cancer. The dilemna is "what DCIS does turn to cancer" therefore, all of DCIS is removed to take away this chance.

As for those with DCIS that got micromets in the node, it is because there had to be a tiny spot that was missed as invasive cancer. Tiny, tiny spots can be missed. But you did NOT even have DCIS yet (and maybe never would). You may have inflammed and sore nodes from the port. How many Herceptin treatments do you have left? Do you need the port? Can you get the port replaced elsewhere? Just asking

I think your pathology is wonderful news. Smile away at this.

Love,

[Lani]

your pathology report is not even close to listing microscopic tissues described as possibly pre-malignant (at least according to the literature I have read)

invasive ductal or lobular are the premalignant entities and it is often cited that the precursors of these MAY BE atypical ductal or lobular hyperplasia.

As your hyperplasia does not involve any atypical cells it would not even be considered pre-pre-malignant.

If you lift weights or exercise, you get hyperplasia of your muscles. It is a benign enlargement. In a woman, the breast tissues change with the menstrual cycle and at some time or other all women have hyperplasia of their breasts. I have no idea what degree florid is, but if you were premenopausal at the time of your prophylactic mastectomy, you might want to try to figure out what stage of the menstrual cycle you were in at the time of your operation.

Seems to me your report should be a reason to rejoice rather than worry!

[Lani]

ABSTRACT: Is Routine Sentinel Lymph Node Biopsy Indicated in Women Undergoing Contralateral Prophylactic Mastectomy? Magee-Womens Hospital Experience [Annals of Surgical Oncology
]
Introduction: The routine use of sentinel node biopsy (SLNB) at the time of prophylactic mastectomy remains controversial. This retrospective study was undertaken to determine if SLNB is justified in patients undergoing CPM.

Methods: Between 1999 and 2004, 155 patients underwent contralateral prophylactic mastectomy (CPM) at the Magee-Womens Hospital of University of Pittsburgh Medical Center. Eighty patients (51.6%) had SLNB performed at the time of CPM. The therapeutic mastectomy and the CPM specimens were evaluated for histopathology. Goldflam's classification was used to determine the risk of malignancy in the CPM specimens.

Results: Pathology in the therapeutic mastectomy specimens included 105 (68%) invasive carcinomas and 50 (32%) insitu carcinomas. Multicentricity and/or multifocality were reported in 49.7%, and 70% were estrogen receptor positive. Two invasive breast cancers and three cases of DCIS were diagnosed in 155 CPM specimens (n = 5, 3.2%). The median number of SLN identified was 2 (range 1-6) from the CPM axilla. Two patients had positive SLNB for metastatic carcinoma (n = 2/80, 2.5%) with no primary tumor identified in the prophylactic mastectomy specimen. In both patients the therapeutic mastectomy was for recurrent invasive carcinoma in patients with a prior history of axillary node dissection. Occult carcinoma was found in five prophylactic mastectomy specimens: two invasive and three DCIS. Only 1 out of the 75 patients not undergoing SLNB at the time of their initial surgery would have required axillary staging for a previously undiagnosed invasive cancer in the CPM specimen on final pathology. Of all 155 patients undergoing CPM, only 4 (2.5%) had identified final pathologic findings where axillary staging with SLNB was beneficial. There was no evidence of arm lymphedema in any patient who had undergone CPM and SLNB at a median follow-up of 24 months.

Conclusion: Although SLNB is a minimally invasive method of axillary staging, this retrospective study does not support its routine use in patients undergoing CPM.

[saleboat]

Chelee-- your path report sounds wonderful. I hope it gives you the peace of mind you have been seeking.

Jen

[Margerie]

Congrats on your somewhat unremarkable boob! I hope your axilla calms down so you can enjoy life. It probably is sore from all that inflammation in your breast.

I know you have had such stress. Try to rest and recover (at least for a day!)

Have you found your new onc yet? Hope you can make a fresh start with him/her.

[Joy]

Chelee, I'm choosing to think you are all good! And I also hope this is a fresh new start with a fresh new team of docs!